Published in RNA on January 29, 2008
Molecular mechanism for inhibition of g protein-coupled receptor kinase 2 by a selective RNA aptamer. Structure (2012) 1.58
The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol (2010) 1.30
Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures. Nat Protoc (2010) 1.28
Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractility. ACS Chem Biol (2012) 1.19
Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy. Front Physiol (2013) 1.02
Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells. RNA Biol (2012) 0.87
Molecular basis for small molecule inhibition of G protein-coupled receptor kinases. ACS Chem Biol (2014) 0.85
Stabilized Interleukin-6 receptor binding RNA aptamers. RNA Biol (2013) 0.83
Structural insights into G protein-coupled receptor kinase function. Curr Opin Cell Biol (2013) 0.82
d(GGGT) 4 and r(GGGU) 4 are both HIV-1 inhibitors and interleukin-6 receptor aptamers. RNA Biol (2012) 0.81
By-product formation in repetitive PCR amplification of DNA libraries during SELEX. PLoS One (2014) 0.79
Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine. J Med Chem (2017) 0.78
The role of HTS in drug discovery at the University of Michigan. Comb Chem High Throughput Screen (2014) 0.78
Modular Assembly of Cell-targeting Devices Based on an Uncommon G-quadruplex Aptamer. Mol Ther Nucleic Acids (2015) 0.78
Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors. J Med Chem (2016) 0.76
"Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors. Front Cardiovasc Med (2016) 0.75
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol (1973) 47.81
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (1990) 35.96
The protein kinase complement of the human genome. Science (2002) 35.36
In vitro selection of RNA molecules that bind specific ligands. Nature (1990) 30.19
Transduction of receptor signals by beta-arrestins. Science (2005) 9.87
In vitro selection of functional nucleic acids. Annu Rev Biochem (1999) 6.55
G protein-coupled receptor kinases. Annu Rev Biochem (1998) 5.53
Seven-transmembrane-spanning receptors and heart function. Nature (2002) 5.38
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation (1993) 4.52
Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science (1995) 4.18
Features of selective kinase inhibitors. Chem Biol (2005) 4.07
Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol (2007) 3.27
Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med (2007) 2.48
Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Science (2005) 2.46
Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature (2006) 2.40
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature (2003) 2.38
The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta (2006) 2.24
Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J (1995) 2.07
Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta (1993) 2.02
Protein-dependent ribozymes report molecular interactions in real time. Nat Biotechnol (2002) 2.00
Isolation of high-affinity GTP aptamers from partially structured RNA libraries. Proc Natl Acad Sci U S A (2002) 1.74
Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res (1994) 1.66
Automated selection of anti-protein aptamers. Bioorg Med Chem (2001) 1.60
The ins and outs of G protein-coupled receptor trafficking. Trends Biochem Sci (2003) 1.56
G protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization. J Biol Chem (1997) 1.55
RNA bulges as architectural and recognition motifs. Structure (2000) 1.55
Selective optimization of the Rev-binding element of HIV-1. Nucleic Acids Res (1993) 1.40
A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Protein Sci (1998) 1.39
Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. Nucleic Acids Res (2002) 1.29
Pharmacological inhibition of protein kinases in intact cells: antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitations of usefulness. J Pharmacol Exp Ther (1999) 1.27
Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK. Curr Biol (2006) 1.25
G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol Endocrinol (2005) 1.23
Controlling small guanine-nucleotide-exchange factor function through cytoplasmic RNA intramers. Proc Natl Acad Sci U S A (2001) 1.20
Cloning and expression of GRK5: a member of the G protein-coupled receptor kinase family. Proc Natl Acad Sci U S A (1993) 1.19
Conformational changes in the expression domain of the Escherichia coli thiM riboswitch. Nucleic Acids Res (2007) 1.17
Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. J Leukoc Biol (2004) 1.16
Inhibition of beta-adrenergic receptor kinase prevents rapid homologous desensitization of beta 2-adrenergic receptors. Proc Natl Acad Sci U S A (1989) 1.14
Expression and characterization of two beta-adrenergic receptor kinase isoforms using the baculovirus expression system. Receptor (1993) 1.13
Isozyme-specific inhibition of protein kinase C by RNA aptamers. J Biol Chem (1994) 1.10
GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. EMBO J (2004) 1.10
The beta-adrenergic receptor kinase in heart failure. J Mol Cell Cardiol (2003) 1.06
The GRK4 subfamily of G protein-coupled receptor kinases. Alternative splicing, gene organization, and sequence conservation. J Biol Chem (1999) 1.02
Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases. Proc Natl Acad Sci U S A (1996) 1.02
Discriminatory aptamer reveals serum response element transcription regulated by cytohesin-2. Proc Natl Acad Sci U S A (2004) 1.02
Protein kinase cross-talk: membrane targeting of the beta-adrenergic receptor kinase by protein kinase C. Proc Natl Acad Sci U S A (1996) 1.01
Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease. Mol Interv (2003) 0.99
Chemical genetic engineering of G protein-coupled receptor kinase 2. J Biol Chem (2005) 0.97
Internalization and recycling of delta-opioid receptor are dependent on a phosphorylation-dephosphorylation mechanism. J Pharmacol Exp Ther (2000) 0.97
RNA aptamers as pathway-specific MAP kinase inhibitors. Chem Biol (2000) 0.96
Aptamers and aptazymes: accelerating small molecule drug discovery. Curr Opin Drug Discov Devel (2002) 0.92
G-protein-coupled receptor kinases. Kidney Int (1996) 0.91
Intramers and aptamers: applications in protein-function analyses and potential for drug screening. Chembiochem (2005) 0.91
Peptide inhibitors of G protein-coupled receptor kinases. Biochem Pharmacol (2005) 0.91
RNA ligands that distinguish metabolite-induced conformations in the TPP riboswitch. Angew Chem Int Ed Engl (2007) 0.91
Characterisation of antibody-binding RNAs selected from structurally constrained libraries. Nucleic Acids Res (1996) 0.90
Aptamers as tools for target prioritization and lead identification. Drug Discov Today (2002) 0.88
The amino-terminal domain of G-protein-coupled receptor kinase 2 is a regulatory Gbeta gamma binding site. J Biol Chem (2002) 0.87
Role of G-protein-coupled receptor kinase 2 in the heart--do regulatory mechanisms open novel therapeutic perspectives? Trends Cardiovasc Med (2006) 0.87
Oxidative stress decreases G protein-coupled receptor kinase 2 in lymphocytes via a calpain-dependent mechanism. Mol Pharmacol (2002) 0.85
Anti-idiotype RNA selected with an anti-nuclear export signal antibody is actively transported in oocytes and inhibits Rev- and cap-dependent RNA export. Proc Natl Acad Sci U S A (1997) 0.85
Role of G protein-coupled receptor kinase 2 and arrestins in beta-adrenergic receptor internalization. Trends Cardiovasc Med (1998) 0.84
Molecular modeling of G-protein coupled receptor kinase 2: docking and biochemical evaluation of inhibitors. AAPS PharmSci (2000) 0.81
Therapeutic potential of G-protein coupled receptor kinases in the heart. Expert Opin Investig Drugs (1999) 0.80
Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem (2004) 5.00
A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat Methods (2005) 3.11
Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science (2010) 2.99
Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat Biotechnol (2003) 2.84
Widespread receptivity to neuropeptide PDF throughout the neuronal circadian clock network of Drosophila revealed by real-time cyclic AMP imaging. Neuron (2008) 2.73
Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling. Circ Res (2006) 2.66
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol Rev (2007) 2.62
Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. PLoS Biol (2009) 2.59
Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases. Circ Res (2004) 2.58
Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc Natl Acad Sci U S A (2003) 2.52
Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. Nat Chem Biol (2008) 2.51
Building a new conceptual framework for receptor heteromers. Nat Chem Biol (2009) 2.41
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature (2003) 2.38
Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation (2002) 2.10
Dynamics of receptor/G protein coupling in living cells. EMBO J (2005) 2.06
Analysis of receptor oligomerization by FRAP microscopy. Nat Methods (2009) 2.06
The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med (2005) 2.02
Fluorescent sensors for rapid monitoring of intracellular cGMP. Nat Methods (2006) 1.96
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N Engl J Med (2014) 1.89
μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization. Mol Pharmacol (2010) 1.83
Determination of onset of sexual maturation and mating behavior by melanocortin receptor 4 polymorphisms. Curr Biol (2010) 1.82
Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization. Proc Natl Acad Sci U S A (2012) 1.82
G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacol Rev (2014) 1.82
Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line. J Biol Chem (2005) 1.80
Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice. Circ Res (2002) 1.79
Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest (2004) 1.77
Sweet taste receptor expressed in pancreatic beta-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion. PLoS One (2009) 1.71
Signaling by internalized G-protein-coupled receptors. Trends Pharmacol Sci (2010) 1.70
Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. Proc Natl Acad Sci U S A (2005) 1.63
Molecular basis of inverse agonism in a G protein-coupled receptor. Nat Chem Biol (2005) 1.60
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat Med (2008) 1.56
G Protein activation without subunit dissociation depends on a G{alpha}(i)-specific region. J Biol Chem (2005) 1.55
Gs activation is time-limiting in initiating receptor-mediated signaling. J Biol Chem (2006) 1.52
Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J Biol Chem (2005) 1.50
FRET measurements of intracellular cAMP concentrations and cAMP analog permeability in intact cells. Nat Protoc (2011) 1.45
Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol. J Clin Invest (2007) 1.44
A geometric approach for the alignment of liquid chromatography-mass spectrometry data. Bioinformatics (2007) 1.44
Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling. Int J Biochem Cell Biol (2009) 1.39
Internalization determinants of the parathyroid hormone receptor differentially regulate beta-arrestin/receptor association. J Biol Chem (2001) 1.37
Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation. Circulation (2004) 1.36
Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. Mol Endocrinol (2003) 1.33
Real-time monitoring of the PDE2 activity of live cells: hormone-stimulated cAMP hydrolysis is faster than hormone-stimulated cAMP synthesis. J Biol Chem (2004) 1.30
Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function. Proc Natl Acad Sci U S A (2006) 1.29
Fluorescent labeling of tetracysteine-tagged proteins in intact cells. Nat Protoc (2010) 1.28
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability. J Biol Chem (2013) 1.26
Monitoring of cAMP synthesis and degradation in living cells. Physiology (Bethesda) (2006) 1.20
Differential signaling of the endogenous agonists at the beta2-adrenergic receptor. J Biol Chem (2010) 1.20
Persistent cAMP signaling by internalized TSH receptors occurs in thyroid but not in HEK293 cells. FASEB J (2012) 1.17
GPCR and G proteins: drug efficacy and activation in live cells. Mol Endocrinol (2009) 1.16
Ca2+ cycling and new therapeutic approaches for heart failure. Circulation (2010) 1.16
Multidomain targeting generates a high-affinity thrombin-inhibiting bivalent aptamer. Chembiochem (2007) 1.15
Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2. J Biol Chem (2008) 1.14
Molecular basis of partial agonism at the neurotransmitter alpha2A-adrenergic receptor and Gi-protein heterotrimer. J Biol Chem (2006) 1.14
A role for caspase-1 in heart failure. Circ Res (2007) 1.13
Endomorphin-2: a biased agonist at the μ-opioid receptor. Mol Pharmacol (2012) 1.10
Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathy. Circulation (2003) 1.10
Dual role of the beta2-adrenergic receptor C terminus for the binding of beta-arrestin and receptor internalization. J Biol Chem (2008) 1.09
GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base. Bioinformatics (2010) 1.09
SUMO-1 controls the protein stability and the biological function of phosducin. J Biol Chem (2006) 1.08
A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes. J Med Chem (2011) 1.08
A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol (2007) 1.07
Cytoplasmic cAMP concentrations in intact cardiac myocytes. Am J Physiol Cell Physiol (2008) 1.07
Distinct pools of cAMP centre on different isoforms of adenylyl cyclase in pituitary-derived GH3B6 cells. J Cell Sci (2010) 1.06
Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signaling by protein kinase C and beta-arrestins. Endocrinology (2002) 1.06
Regulation of the inward rectifying properties of G-protein-activated inwardly rectifying K+ (GIRK) channels by Gbeta gamma subunits. J Biol Chem (2002) 1.05
Simultaneous optical measurements of cytosolic Ca2+ and cAMP in single cells. Sci STKE (2006) 1.04
Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2003) 1.04
Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base. BMC Bioinformatics (2007) 1.04
Phosducin-like protein regulates G-protein betagamma folding by interaction with tailless complex polypeptide-1alpha: dephosphorylation or splicing of PhLP turns the switch toward regulation of Gbetagamma folding. J Biol Chem (2005) 1.04
Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J (2006) 1.04
FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors. Bioorg Med Chem (2010) 1.03
Chronic acromioclavicular separation: the medium term results of coracoclavicular ligament reconstruction using braided polyester prosthetic ligament. Injury (2007) 1.03
Magnesium and the parathyroid. Curr Opin Nephrol Hypertens (2002) 1.03
cAMP microdomains and L-type Ca2+ channel regulation in guinea-pig ventricular myocytes. J Physiol (2007) 1.02
beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy. Trends Cardiovasc Med (2006) 1.01
Sequential inter- and intrasubunit rearrangements during activation of dimeric metabotropic glutamate receptor 1. Sci Signal (2012) 1.01
A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling. Immunol Lett (2008) 1.00
Mutation of Asn293 to Asp in transmembrane helix VI abolishes agonist-induced but not constitutive activity of the beta(2)-adrenergic receptor. Mol Pharmacol (2002) 1.00
Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a receptor activated solely by synthetic ligand (RASSL). Mol Pharmacol (2011) 1.00
Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. J Clin Invest (2009) 0.98
Structure-kinetic relationship study of CDK8/CycC specific compounds. Proc Natl Acad Sci U S A (2013) 0.98
Interstitial remodeling in beta1-adrenergic receptor transgenic mice. Basic Res Cardiol (2006) 0.97
Sensing G protein-coupled receptor activation. Neuropharmacology (2010) 0.97
Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists. Cardiovasc Res (2004) 0.97
Aptamers as tools for target validation. Curr Opin Chem Biol (2005) 0.97
Imaging of persistent cAMP signaling by internalized G protein-coupled receptors. J Mol Endocrinol (2010) 0.96
Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway. J Hepatol (2003) 0.96
Pathological autoantibodies in cardiomyopathy. Autoimmunity (2008) 0.94
Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy. Proc Natl Acad Sci U S A (2013) 0.93
Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6. Mol Med (2007) 0.93
Cell biology: Receptor signals come in waves. Nature (2013) 0.93
β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway. Cardiovasc Res (2012) 0.92
Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor. Circulation (2003) 0.92